The PLR is an objective indicator of retina and optic nerve function after light stimulation. A very important clinical application of the PLR observation is assessing a disease-induced afferent deficit, which can affect retina, optic nerve, and anterior, pregeniculate visual pathways (chiasm, optic tract, and midbrain pathways). The past 5 years have seen a revolutionary advancement in the understanding of the physiological basis of photoreceptor and nonphotoreceptor-mediated PLR activity.
28 29 30 31 Discovery of the vitamin A–based photosensitive pigment (melanopsin) in retinal ganglion cells projecting to midbrain structures mediating PLR activity, circadian rhythm regulation, and visual processing provides a principal explanation for the existence of intact PLR activity in eyes with virtually complete damage to the photoreceptor layer.
29 31 32 Traditionally, clinical testing of PLR activity is performed with nonchromatic white light stimuli of different light intensities. Our study in healthy dogs and dogs with SARDS has demonstrated that rod-cone–mediated PLR activity can be elicited with light stimuli below the 3 log units light intensity, whereas possible exclusive melanopsin-mediated PLR could be elicited with much a higher light stimulus (4.3 log units or higher). Furthermore, we demonstrated that the separation of melanopsin and nonmelanopsin (rod-cone–mediated) PLR components can possibly be achieved by using light stimuli of different wavelengths (blue vs. red response). Because melanopsin sensitivity peaks close to 480 nm of wavelength (blue light), blue colored light stimuli of sufficient light intensity can be conveniently used to evaluate function of melanopsin-containing retinal ganglion cells
28 lacking in rod-cone input (which is most likely the case in dogs with SARDS) and, hence, optic nerve function. Use of red light (630 nm), with a wavelength that does not overlap with melanopsin sensitivity, can be conveniently used to test for the cone photoreceptor–mediated component of the PLR.
28 30 Previous studies of photopigments in dogs with visual behavior and electroretinography testing showed that canine retina has one rod pigment with peak sensitivity at 508 nm and two cone pigments with peak sensitivities at 430 to 435 nm (short-wavelength sensitivity) and 555 nm (long-wavelength sensitivity).
33 34 Given that we used a red light of high wavelength (630 nm), it is likely that we managed to activate primarily the cones with long-wave sensitivity pigment because previous studies demonstrated end spectral sensitivity in the range of 650 nm. However, we cannot absolutely exclude the possibility that red light of 630 nm and high intensity did not also activate the rod system because of a very wide range of sensitivity of rod pigments in canine retina (peak sensitivity at 508 nm but end-of-sensitivity curve well in the range of 630 nm).
34 Because SARDS dogs do not have any PLR responses with red light but have good responses with blue light (480 nm) and do not have detectable rod- or cone-mediated ERG activity, we hypothesized that observed responses are indeed a result of melanopsin-mediated activity rather than residual photoreceptor activity (with a short-wavelength sensitivity
34 ), which could not be detected by standard electroretinography. Several factors support our hypothesis. The wavelength of blue light used in our study (480 nm) corresponds to the previously published peak spectral sensitivity of melanopsin in different species and falls between peak spectral sensitivity for cone and rod pigments in canine retina; we had to use the blue light of very high intensity to reliably induce PLR responses in SARDS dogs (5.3 log units = 200,000 cd/m
2). Although we showed that latency data in healthy canine eyes is in the range of 150 to 220 ms, we never managed to induce PLR responses in SARDS dogs with light stimuli of 0.2 to 1 seconds, which again is indirect evidence that observed pupil light responses in SARDS dogs correspond by increased latency to previously described melanopsin-mediated responses.